logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US
logo-top-c-r
logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US

Market Access Advisory Board Meetings: Bridging the Gap Between Market Access and Internal Stakeholders

April 4, 2017
-
Publications
-
Posted by MORSE Team - < 1 min read.

Dominika Dabrowski (DKDA Consulting), Arvind Mani (MORSE Consulting), and Sherry O’Quinn (MORSE Consulting) have collaborated on an article that describes best practices for organizing and executing effective market access Advisory Board Meetings.

Market Access teams often bridge the Clinical and Commercial silos, and as such, Market Access Managers play a critical role in the development and implementation of effective strategies that need to satisfy competing department objectives. One of the tools available to Market Access Managers that can help align these conflicting priorities is the Advisory Board Meeting.

Undertaking an Advisory Board Meeting requires a significant investment of both time and budget. This article highlights a number of best practices that will help to ensure a successful meeting, and maximize the return on this investment.

A copy of the article can be downloaded here.

 

To receive timely industry updates and insights please be sure to sign up for Market Access Signals, our free e-mail newsletter service.

 

Share
Tags
Ad Board
Advisory Board
Market Access Advisory Board
Payer Research
Pharmaceutical Ad Board
← PREVIOUS POST
Introducing the MORSE KEY - a New Reimbursement Events Calendar
NEXT POST →
pCPA Update as of February 28, 2017

Contact Us
MORSE Consulting Inc.
Toronto | Ottawa, Canada
+1-647-717-3179 (Toronto)
+1-613-864-8645 (Ottawa)
info@morseconsulting.ca
Social
Connect & Follow:

New Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2021 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
Market Access Advisory Board Meetings: Bridging the Gap Between Market Access and Internal Stakeholders
Private
Public
Private

INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB

Public
INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB
Public
Private
Public
INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB
Private

INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB